EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease

Kirk M Welker iD, David Joyner iD, Anthony W Kam iD, David S Liebeskind iD, Amit M Saindane iD, Colin Segovis iD, Noushin Yahyavi-Firouz-Abadi iD, John E Jordan iD

American Journal of Neuroradiology · 2025-02 · 46 (2) · 227-230

DOI: 10.3174/ajnr.a8501 ↗

Kurz gefasst

Leitlinie in der Zeitschrift American Journal of Neuroradiology, online erschienen am 16.09.2024. Verfasst von Kirk M Welker und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology (K.M.W.), Mayo Clinic, Rochester, Minnesota welker.kirk@mayo.edu. Hauptthemen laut MEDLINE: Contrast Media, Renal Insufficiency, Chronic, Gadolinium, Magnetic Resonance Imaging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaRenal Insufficiency, ChronicGadoliniumMagnetic Resonance ImagingNephrogenic Fibrosing DermopathyNeuroimagingHumansSocieties, Medical

Substanzen

Contrast MediaGadolinium

Autor:innen und Institutionen

  • From the Department of Radiology (K.M.W.), Mayo Clinic, Rochester, Minnesota welker.kirk@mayo.edu.
  • Department of Radiology and Medical Imaging (D.J.), University of Virginia, Charlottesville, Virginia.
  • Department of Radiology (A.W.K.), Loyola University Medical Center, Maywood, Illinois.
  • Department of Neurology (D.S.L.), University of California Los Angeles, Los Angeles, California.
  • Department of Radiology and Imaging Sciences (A.M.S., C.S.), Emory University School of Medicine, Atlanta, Georgia.
  • Department of Radiology and Nuclear Medicine (N.Y.-F.-A.), University of Maryland School of Medicine, Baltimore, Maryland.

ORCID-Profile: Kirk M Welker, David Joyner, Anthony W Kam, David S Liebeskind, Amit M Saindane, Colin Segovis, Noushin Yahyavi-Firouz-Abadi, John E Jordan

Zitieren

APA

Welker, K. M., Joyner, D., Kam, A. W., Liebeskind, D. S., Saindane, A. M., Segovis, C., Yahyavi-Firouz-Abadi, N., & Jordan, J. E. (2025). State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease. American Journal of Neuroradiology, 46(2), 227-230. https://doi.org/10.3174/ajnr.a8501

Vancouver

Welker KM, Joyner D, Kam AW, Liebeskind DS, Saindane AM, Segovis C, et al. State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease. American Journal of Neuroradiology. 2025;46(2):227-230. doi:10.3174/ajnr.a8501

BibTeX
@article{Welker2025,
  author = {Welker, Kirk M and Joyner, David and Kam, Anthony W and Liebeskind, David S and Saindane, Amit M and Segovis, Colin and Yahyavi-Firouz-Abadi, Noushin and Jordan, John E},
  title = {State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease},
  journal = {American Journal of Neuroradiology},
  year = {2025},
  volume = {46},
  number = {2},
  pages = {227--230},
  doi = {10.3174/ajnr.a8501}
}
Kostenlos starten →